$PPH News 26 ways to profit from ‘Obamacare’
Post# of 102233
Posted On: 03/10/2014 9:59:10 AM
$PPH News
26 ways to profit from ‘Obamacare’ 7:01 a.m. Nov. 8, 2012 - The Trading Deck
How to play a post-election stock market 7:45 a.m. Nov. 6, 2012 - The Trading Deck
Obama or Romney, pharma is a loser 11:45 a.m. Aug. 15, 2012 - The Trading Deck
Pharma Patent Cliff: Why Worst Seems Over 6:08 p.m. Feb. 28, 2014 - Seeking Alpha
Health care sector at rare premium to consumer staples 11:35 a.m. Feb. 14, 2014 - Seeking Alpha
Northwest Is A Good Long-Term Bet 10:57 a.m. Feb. 14, 2014 - Seeking Alpha
Why La Jolla Pharma Has Very Favorable Risk/Reward 3:52 p.m. Feb. 5, 2014 - Seeking Alpha
The Acquisition Of Mills Pharmaceuticals Put Another Arrow In The Quiver Of Galena 6:07 p.m. Jan. 27, 2014 - Seeking Alpha
Seattle Genetics Will Exceed And Immunogen Will Meet Market Expectations 11:09 a.m. Jan. 25, 2014 - Seeking Alpha
Big Pharmas Battle For The Billion-Dollar Melanoma Market 6:42 p.m. Jan. 24, 2014 - Seeking Alpha
Private Customers Continue To Fuel Revenue Upside At Illumina 11:24 a.m. Jan. 21, 2014 - Seeking Alpha
All Signs Point To Geron's Imetelstat Being The Holy Grail Of Myeloproliferative Drugs 2:37 p.m. Jan. 17, 2014 - Seeking Alpha
AstraZeneca: Should You Buy This 4.5% Yielder? 11:56 a.m. Jan. 16, 2014 - Seeking Alpha
StemCells CEO Writes Letter To Shareholders, Identifies Upcoming Catalysts 2:14 p.m. Jan. 10, 2014 - Seeking Alpha
3 Attractive Low P/E ETFs For Investors to Consider Today 7:03 a.m. Jan. 10, 2014 - InvestorPlace.com
Low P/E ETFs Become Less Risky When They Boast Technical Uptrends 5:56 p.m. Jan. 9, 2014 - Seeking Alpha
Forxiga Approval Should Be Boon For AstraZeneca And Bristol-Myers Squibb 1:16 p.m. Jan. 9, 2014 - Seeking Alpha
Why Investors Should Be Constantly Monitoring These Stocks 8:48 a.m. Jan. 9, 2014 - Seeking Alpha
New ED Drug: Analysis Of Vivus's Prospects 6:18 p.m. Jan. 8, 2014 - Seeking Alpha
Aeolus Pharmaceuticals: A Biodefense Nano-Cap With Noteworthy Partners 5:04 p.m. Jan. 8, 2014 - Seeking Alpha
In Conversation With Bing Yao 11:21 a.m. Jan. 8, 2014 - Seeking Alpha
An Introduction To Neurotrophic Factors As Treatment For Neurodegenerative Diseases 1:03 p.m. Jan. 7, 2014 - Seeking Alpha
Sophiris Bio: Recent Price Action Offers An Attractive Entry Point 10:42 a.m. Dec. 31, 2013 - Seeking Alpha
March 2013 Distributions for Market Vectors Bank and Brokerage ETF and Market Vectors Pharmaceutical ETF 4:30 p.m. March 28, 2013 - BusinessWire
26 ways to profit from ‘Obamacare’ 7:01 a.m. Nov. 8, 2012 - The Trading Deck
How to play a post-election stock market 7:45 a.m. Nov. 6, 2012 - The Trading Deck
Obama or Romney, pharma is a loser 11:45 a.m. Aug. 15, 2012 - The Trading Deck
Pharma Patent Cliff: Why Worst Seems Over 6:08 p.m. Feb. 28, 2014 - Seeking Alpha
Health care sector at rare premium to consumer staples 11:35 a.m. Feb. 14, 2014 - Seeking Alpha
Northwest Is A Good Long-Term Bet 10:57 a.m. Feb. 14, 2014 - Seeking Alpha
Why La Jolla Pharma Has Very Favorable Risk/Reward 3:52 p.m. Feb. 5, 2014 - Seeking Alpha
The Acquisition Of Mills Pharmaceuticals Put Another Arrow In The Quiver Of Galena 6:07 p.m. Jan. 27, 2014 - Seeking Alpha
Seattle Genetics Will Exceed And Immunogen Will Meet Market Expectations 11:09 a.m. Jan. 25, 2014 - Seeking Alpha
Big Pharmas Battle For The Billion-Dollar Melanoma Market 6:42 p.m. Jan. 24, 2014 - Seeking Alpha
Private Customers Continue To Fuel Revenue Upside At Illumina 11:24 a.m. Jan. 21, 2014 - Seeking Alpha
All Signs Point To Geron's Imetelstat Being The Holy Grail Of Myeloproliferative Drugs 2:37 p.m. Jan. 17, 2014 - Seeking Alpha
AstraZeneca: Should You Buy This 4.5% Yielder? 11:56 a.m. Jan. 16, 2014 - Seeking Alpha
StemCells CEO Writes Letter To Shareholders, Identifies Upcoming Catalysts 2:14 p.m. Jan. 10, 2014 - Seeking Alpha
3 Attractive Low P/E ETFs For Investors to Consider Today 7:03 a.m. Jan. 10, 2014 - InvestorPlace.com
Low P/E ETFs Become Less Risky When They Boast Technical Uptrends 5:56 p.m. Jan. 9, 2014 - Seeking Alpha
Forxiga Approval Should Be Boon For AstraZeneca And Bristol-Myers Squibb 1:16 p.m. Jan. 9, 2014 - Seeking Alpha
Why Investors Should Be Constantly Monitoring These Stocks 8:48 a.m. Jan. 9, 2014 - Seeking Alpha
New ED Drug: Analysis Of Vivus's Prospects 6:18 p.m. Jan. 8, 2014 - Seeking Alpha
Aeolus Pharmaceuticals: A Biodefense Nano-Cap With Noteworthy Partners 5:04 p.m. Jan. 8, 2014 - Seeking Alpha
In Conversation With Bing Yao 11:21 a.m. Jan. 8, 2014 - Seeking Alpha
An Introduction To Neurotrophic Factors As Treatment For Neurodegenerative Diseases 1:03 p.m. Jan. 7, 2014 - Seeking Alpha
Sophiris Bio: Recent Price Action Offers An Attractive Entry Point 10:42 a.m. Dec. 31, 2013 - Seeking Alpha
March 2013 Distributions for Market Vectors Bank and Brokerage ETF and Market Vectors Pharmaceutical ETF 4:30 p.m. March 28, 2013 - BusinessWire
(0)
(0)Scroll down for more posts ▼